Tighter Gene‑Therapy Regulation: Robust Preclinical Animal Data Has Become the “Admission Ticket” for Clinical Research
In recent years, gene‑editing and AAV‑based gene therapies have frequently made headlines, hailed as beacons of hope for curing genetic diseases. What many overlook, however, is that before these cutting‑edge therapies advance to human trials, they must repeatedly pass a…



